Abstract

Parkinson’s disease (PD), the second most common neurodegenerative disorder, is characterized by dopaminergic neuronal loss that initiates in the substantia nigra pars compacta and by the formation of intracellular inclusions mainly constituted by aberrant α-synuclein (α-syn) deposits known as Lewy bodies. Most cases of PD are sporadic, but about 10% are familial, among them those caused by mutations in SNCA gene have an autosomal dominant transmission. SNCA encodes α-syn, a small 140-amino acids protein that, under physiological conditions, is mainly localized at the presynaptic terminals. It is prevalently cytosolic, but its presence has been reported in the nucleus, in the mitochondria and, more recently, in the mitochondria-associated ER membranes (MAMs). Whether different cellular localizations may reflect specific α-syn activities is presently unclear and its action at mitochondrial level is still a matter of debate. Mounting evidence supports a role for α-syn in several mitochondria-derived activities, among which maintenance of mitochondrial morphology and modulation of complex I and ATP synthase activity. α-syn has been proposed to localize at the outer membrane (OMM), in the intermembrane space (IMS), at the inner membrane (IMM) and in the mitochondrial matrix, but a clear and comparative analysis of the sub-mitochondrial localization of WT and mutant α-syn is missing. Furthermore, the reasons for this spread sub-mitochondrial localization under physiological and pathological circumstances remain elusive. In this context, we decided to selectively monitor the sub-mitochondrial distribution of the WT and PD-related α-syn mutants A53T and A30P by taking advantage from a bimolecular fluorescence complementation (BiFC) approach. We also investigated whether cell stress could trigger α-syn translocation within the different mitochondrial sub-compartments and whether PD-related mutations could impinge on it. Interestingly, the artificial targeting of α-syn WT (but not of the mutants) to the mitochondrial matrix impacts on ATP production, suggesting a potential role within this compartment.

Highlights

  • Parkinson’s disease (PD) affects 6 million individuals worldwide

  • WT and mutant α-syn reside at the outer membrane (OMM) and intermembrane space (IMS) but not in the mitochondrial matrix and their overexpression modulates mitochondrial ATP production To investigate the sub-mitochondrial localization of WT α-syn and its pathologic mutants, we co-transfected HeLa (Fig. 1b) and SHSY5Y neuroblastoma (Fig. 1c) cells with the above described GFP1-10 constructs and the untargeted WT, A53T and A30P α-syn fused at their Cterminal with the S11 β-strand

  • Complementation of the GFP probes was revealed by fluorescent acquisition at 488 nm excitation wavelength. d Mitochondrial (****p < 0.0001 vs. control cells) and e cytosolic ATP production upon histamine stimulation measured by mtLuc probe in HeLa cells overexpressing α-syn wt and mutants

Read more

Summary

Introduction

Vicario et al Cell Death and Disease (2019)10:857 cellular and animal models where the expression level of α-syn was manipulated by overexpression and/or silencing and where α-syn mutants were introduced. Accumulation of WT α-syn causes a reduction in mitochondrial complex I activity[14,20,21,22] while α-syn null mice display striking resistance to the neurotoxin 1-. Alterations including increased oxidative stress, lipid abnormalities, complex I deficiency, increased mitochondrial fragmentation, loss of membrane potential and cytochrome c release were reported in mutant α-syn transgenic[25,26] and null mice[27], as well as in cells overexpressing wt α-syn[28]. We have previously demonstrated that α-syn positively enhanced mitochondrial Ca2+ transients generated upon Ca2+ release from the endoplasmic reticulum (ER) by increasing the ER-mitochondria contact sites[32]. A dosedependent mechanism of this action has been proposed by us[32] and, more recently, confirmed to be important for α-syn modulation of other mitochondria related activities[33,34,35]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.